Bio-Techne Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD 313.40 M

Bio-Techne Corporation EBITDA is USD 313.40 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -15.69% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Bio-Techne Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 371.74 M, a -2.46% change year over year.
  • Bio-Techne Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 381.10 M, a 15.16% change year over year.
  • Bio-Techne Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 330.92 M, a 2.48% change year over year.
  • Bio-Techne Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 322.90 M, a 41.84% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)